147 related articles for article (PubMed ID: 30091466)
1. Bone-targeted delivery of TGF-β type 1 receptor inhibitor rescues uncoupled bone remodeling in Camurati-Engelmann disease.
Qin Y; Tang S; Zhen G; Ding Q; Ding S; Cao X
Ann N Y Acad Sci; 2018 Dec; 1433(1):29-40. PubMed ID: 30091466
[TBL] [Abstract][Full Text] [Related]
2. Aberrant activation of TGF-β1 induces high bone turnover
Chen Q; Yao Y; Chen K; Chen X; Li B; Li R; Mo L; Hu W; Zhang M; Wang Z; Wu Y; Wu Y; Liu F
Front Endocrinol (Lausanne); 2022; 13():913979. PubMed ID: 36325441
[TBL] [Abstract][Full Text] [Related]
3. An ENU-induced p.C225S missense mutation in the mouse Tgfb1 gene does not cause Camurati-Engelmann disease-like skeletal phenotypes.
Ichimura S; Sasaki S; Murata T; Fukumura R; Gondo Y; Ikegawa S; Furuichi T
Exp Anim; 2017 May; 66(2):137-144. PubMed ID: 27928112
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation.
Tang Y; Wu X; Lei W; Pang L; Wan C; Shi Z; Zhao L; Nagy TR; Peng X; Hu J; Feng X; Van Hul W; Wan M; Cao X
Nat Med; 2009 Jul; 15(7):757-65. PubMed ID: 19584867
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease.
Janssens K; Gershoni-Baruch R; Guañabens N; Migone N; Ralston S; Bonduelle M; Lissens W; Van Maldergem L; Vanhoenacker F; Verbruggen L; Van Hul W
Nat Genet; 2000 Nov; 26(3):273-5. PubMed ID: 11062463
[TBL] [Abstract][Full Text] [Related]
6. Domain-specific mutations of a transforming growth factor (TGF)-beta 1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-beta 1.
Saito T; Kinoshita A; Yoshiura Ki ; Makita Y; Wakui K; Honke K; Niikawa N; Taniguchi N
J Biol Chem; 2001 Apr; 276(15):11469-72. PubMed ID: 11278244
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation of TGF beta1 in a Chinese family with Camurati-Engelmann disease.
Wu S; Liang S; Yan Y; Wang Y; Li F; Deng Y; Huang W; Yuan W; Luo N; Zhu C; Wang Y; Li Y; Liu M; Wu X
Bone; 2007 Jun; 40(6):1630-4. PubMed ID: 17433803
[TBL] [Abstract][Full Text] [Related]
8. Reduced Dentin Matrix Protein Expression in Camurati-Engelmann Disease Transgenic Mouse Model.
Gullard A; Croney CM; Wu X; Mamaeva O; Sohn P; Cao X; MacDougall M
J Cell Physiol; 2016 May; 231(5):1106-13. PubMed ID: 26427011
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein.
Janssens K; ten Dijke P; Ralston SH; Bergmann C; Van Hul W
J Biol Chem; 2003 Feb; 278(9):7718-24. PubMed ID: 12493741
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease.
Campos-Xavier B; Saraiva JM; Savarirayan R; Verloes A; Feingold J; Faivre L; Munnich A; Le Merrer M; Cormier-Daire V
Hum Genet; 2001 Dec; 109(6):653-8. PubMed ID: 11810278
[TBL] [Abstract][Full Text] [Related]
11. Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model.
Rhodes SD; Wu X; He Y; Chen S; Yang H; Staser KW; Wang J; Zhang P; Jiang C; Yokota H; Dong R; Peng X; Yang X; Murthy S; Azhar M; Mohammad KS; Xu M; Guise TA; Yang FC
J Bone Miner Res; 2013 Dec; 28(12):2476-89. PubMed ID: 23703870
[TBL] [Abstract][Full Text] [Related]
12. A mutation affecting the latency-associated peptide of TGFbeta1 in Camurati-Engelmann disease enhances osteoclast formation in vitro.
McGowan NW; MacPherson H; Janssens K; Van Hul W; Frith JC; Fraser WD; Ralston SH; Helfrich MH
J Clin Endocrinol Metab; 2003 Jul; 88(7):3321-6. PubMed ID: 12843182
[TBL] [Abstract][Full Text] [Related]
13. A mutation in TGF beta1 gene encoding the latency-associated peptide in a Chinese patient with Camurati-Engelmann disease.
Liang YH; Li W; Li LY; Ye YY; Lu GX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):502-4. PubMed ID: 17029195
[TBL] [Abstract][Full Text] [Related]
14. Camurati-Engelmann disease--a rare cause of bone pain.
Mundra V; Taxel P
Conn Med; 2012 Jan; 76(1):33-7. PubMed ID: 22372177
[TBL] [Abstract][Full Text] [Related]
15. Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.
Bondestam J; Mäyränpää MK; Ikegawa S; Marttinen E; Kröger H; Mäkitie O
Clin Rheumatol; 2007 Oct; 26(10):1773-7. PubMed ID: 17206397
[TBL] [Abstract][Full Text] [Related]
16. Orthopedic Manifestations of Type I Camurati-Engelmann Disease.
Yuldashev AJ; Shin CH; Kim YS; Jang WY; Park MS; Chae JH; Yoo WJ; Choi IH; Kim OH; Cho TJ
Clin Orthop Surg; 2017 Mar; 9(1):109-115. PubMed ID: 28261436
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of denosumab therapy after alendronate treatment for a 66-year-old woman with Camurati-Engelmann disease and osteoporosis: a case report.
Uehara M; Nakamura Y; Suzuki T; Takahashi J; Kato H
Mod Rheumatol Case Rep; 2020 Jan; 4(1):131-134. PubMed ID: 33086975
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β1 gene mutations and phenotypes in pediatric patients with Camurati‑Engelmann disease.
Wang C; Zhang BH; Liu YJ; Hu YQ; He JW; Zhang ZL
Mol Med Rep; 2013 May; 7(5):1695-9. PubMed ID: 23503840
[TBL] [Abstract][Full Text] [Related]
19. Clinical diagnosis and mutation analysis of a Chinese family with Camurati-Engelmann disease.
Chen Y; Xie W; Hu F; Chen J; Zheng H; Zhou H; Ni B; Li W; Zhou J
Mol Med Rep; 2017 Jan; 15(1):235-239. PubMed ID: 27959412
[TBL] [Abstract][Full Text] [Related]
20. Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.
Whyte MP; Totty WG; Novack DV; Zhang X; Wenkert D; Mumm S
J Bone Miner Res; 2011 May; 26(5):920-33. PubMed ID: 21541994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
